Home » Bayer CEO Sees $15 Billion Market for Xarelto, New Blood Thinners
Bayer CEO Sees $15 Billion Market for Xarelto, New Blood Thinners
The market for new blood thinners including Johnson & Johnson and Bayer AG’s Xarelto could eventually reach $12 billion to $15 billion a year, Bayer Chief Executive Officer Werner Wenning said.
Bloomberg
Bloomberg
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May